{"id":"NCT00522275","sponsor":"UCB BIOSCIENCES, Inc.","briefTitle":"Determine Safety and Efficacy of Long-term Oral Lacosamide in Patients With Partial Seizures","officialTitle":"An Open-label Extension Trial to Determine Safety and Efficacy of Long-term Oral SPM 927 in Patients With Partial Seizures","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2004-10","primaryCompletion":"2009-10","completion":"2009-10","firstPosted":"2007-08-29","resultsPosted":"2010-11-22","lastUpdate":"2018-07-18"},"enrollment":308,"design":{"allocation":"NA","model":"SINGLE_GROUP","masking":"NONE","primaryPurpose":"TREATMENT"},"conditions":["Partial Epilepsies"],"interventions":[{"type":"DRUG","name":"lacosamide","otherNames":[]}],"arms":[{"label":"Lacosamide","type":"EXPERIMENTAL"}],"summary":"The purpose of this trial is to determine whether lacosamide is safe and effective for long-term use in patients with partial-seizures from epilepsy","primaryOutcome":{"measure":"Number of Subjects Reporting at Least 1 Treatment-Emergent Adverse Event (TEAE) During the Treatment Period (Maximum 6 Years)","timeFrame":"During the Treatment Period (Maximum 6 years)","effectByArm":[{"arm":"Lacosamide","deltaMin":288,"sd":null}],"pValues":[]},"eligibility":{"minAge":"16 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":1,"exclusionCount":2},"locations":{"siteCount":60,"countries":["United States"]},"refs":{"pmids":["22372628"],"seeAlso":["http://www.fda.gov/Safety/MedWatch/SafetyInformation/default.htm"]},"adverseEventsSummary":{"seriousAny":{"events":71,"n":308},"commonTop":["Dizziness","Headache","Contusion","Nausea","Nasopharyngitis"]}}